US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Accustem Sciences Inc.

0.6340

0.0000

Volume:7.00

Turnover:4.01

Market Cap:10.19M

PE:- -

High:0.6340

Open:0.6340

Low:0.6340

Close:0.6340

52wk High:2.33

52wk Low:0.2251

Shares:16.07M

Float Shares:9.92M

Volume Ratio:0.01

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

ROE:-1794.16%

ROA:-120.29%

PB:-3.50

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Accustem Sciences Inc.

Exchange:

OTCQB

Establishment Date:

2013

Employees:

2

Office Location:

5 Penn Plaza,19th Floor,#1954,New York,New York,United States

Website:

- -

Zip Code:

10001

Phone:

- -

Fax:

- -

Introduction:

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACUT/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","market":"US","secType":"STK","nameCN":"Accustem Sciences Inc.","latestPrice":0.634,"timestamp":1770749717225,"preClose":0.634,"halted":0,"volume":7,"delay":15,"changeRate":0,"floatShares":9922079,"shares":16072267,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"02-10 13:55:17 EST Delay","open":0.634,"high":0.634,"low":0.634,"amount":4.005,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"exchange":"OTCQB","adjPreClose":0.634,"volumeRatio":0.010670733496616899},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","floatShares":9922079,"roa":"-120.29%","roe":"-1794.16%","lyrEps":0,"volumeRatio":0.010670733496616899,"shares":16072267,"dividePrice":0,"high":0.634,"amplitude":0,"preClose":0.634,"low":0.634,"week52Low":0.2251,"pbRate":"-3.50","week52High":2.33,"institutionHeld":0,"latestPrice":0.634,"eps":0,"divideRate":0,"volume":7,"delay":15,"open":0.634,"prevYearClose":0.81351,"prevWeekClose":0.634,"prevMonthClose":0.6,"prevQuarterClose":0.8135,"fiveDayClose":0.5815,"twentyDayClose":0.846,"sixtyDayClose":0.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-16","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1726459200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-20","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":669855648,"yearFounded":2013,"employeeNum":2,"address":"5 Penn Plaza,19th Floor,#1954,New York,New York,United States","zipCode":"10001"},"stockCompanyDetail":{"description":"AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.","exchange":"OTCQB","name":"Accustem Sciences Inc.","nameEN":"Accustem Sciences Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":null}}